Genetic risk for renal artery stenosis: Association with deletion polymorphism in angiotensin 1-converting enzyme gene

Kidney International

Volumn 49, Issue 2, 1996, Pages 534-537

  Missouris, Constantinos G ^a   Barley, Jacqueline ^a   Jeffery, Steve ^a   Carter, Nicholas D ^a   Singer, Donald R J ^a   Macgregor, Graham A ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0030033189     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.76     Document Type: Article

References (37)

1. MISSOURIS CG, BUCKENHAM T, CAPPUCCIO FP, MACGREGOR GA: Renal artery stenosis: A common and important problem in patients with peripheral vascular disease. Am J Med 96:10-14, 1994
2. MISSOURIS CG, BUCKENHAM T, MACGREGOR GA: Renal artery stenosis and prediction of risk of vascular surgery. Lancet 341:1472, 1993
3. ROBERTS JC, WILLKINS RH, MOSES C: Autopsy studies in atherosclerosis. Circulation XX:520-536, 1959
4. OHISHI M, FUJII K, MINAMINO T, HIGAKI J, KAMITANI A, RAKUGI H, ZHAO Y: A potent genetic risk factor for restenosis. Nature Genet 5:324-325, 1993
5. KASKI JC: Are polymorphisms in the ACE gene a potent genetic risk factor for restenosis? Brit Heart J 72:101, 1994
6. CAMBIEN F, POIRIER O, LECERF L, EVANS A, CAMBOU J-P, ARVEILER D, LUC G: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644, 1992
7. LEATHAM E, BARLEY J, REDWOOD S, HUSSEIN W, CARTER N, JEFFREY S, BATH PMW, CAMM A: Angiotensin-1 converting enzyme (ACE) polymorphism in patients presenting with myocardial infarction or unstable angina. J Hum Hypertens 8:635-638, 1994
8. LUDWIG E, CORNELI PS, ANDERSON JL, MARSHALL HW, LAOULEL JM, WARD RH: Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 91:2120-2124, 1995
9. WIEMER G, SCHOLKENS BA, BECKER RHA, BUSSE R: Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension 18:558-563, 1991
10. KATO H, SUZUKI H, TAJIMA S, OGATA Y, TOMINAGA T, SATO A, SARUTA T: Angiotensin 2 stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens 9:17-22, 1991
11. DAEMAN MJAP, LANBARDI DM, BOSMAN FT, SCHWARTZ SM: Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 68:450-456, 1991
12. POWELL JS, CLOZEL JP, MULLER RKM: Inhibitors of angiotensin-converting enzyme myointimal proliferation after vascular injury. Science 245:186-188, 1989
13. FARHY RD, HO KL, CARRETERO OA, SCICLI AG: Kinins mediate the antiproliferative effect of ramipril in rat carotid artery. Biochem Biophys Res Commun 182:283-288, 1992
14. PELC LR, GROSS GJ, WARLTIER DC: Mechanisms of coronary vasodilation produced by bradykinin. Circulation 83:2048-2056, 1991
15. RIGAT B, HUBERT C, ALHENC-GELAS F, CAMBIEN F, CORVOL P, SOUBRIER F: An insertion/deletion polymorphism in the angiotensin 1 converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990
16. SOUBRIER F, ALHENC-GELAS F, HUBERT C, ALLEGRINI J, JOHN M, TREGEAR S, CORVOL P: Two putative active centers in human angiotensin 1 converting enzyme revealed by molecular cloning. Proc Natl Acad Sci USA 85:9386-9390, 1988
17. ODMAN P, RANNIGER K: The location of the renal arteries. An angiographic and post-mortem study. Am J Roentgenol 104:283-288, 1968
18. GEORGE CF, LEWIS PJ, PETRIE A: Clinical experience with use of ultrasound sphygmomanometer. Brit Heart J 37:804-807, 1975
19. TIRET L, RIGAT B, VISVIKIS S, BREDA C, CORVOL P, CAMBIEN F, SOUBRIER F: Evidence from combined segregation and linkage analysis, that a variant of the angiotensin-1 converting gene controls plasma ACE levels. Am J Hum Genet 51:197-205, 1992
20. SHANMUGAN V, SELL KW, SAHA BK: Mistyping ACE heterozygotes. PCR Meth Appl 3:120-121, 1993
21. EVANS AE, POIRIER O, KEE F, LECERF L, MCCRUM E, FALCONER T, CRANE J, O'ROURKE DF, CAMBIEN F: Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. Quart J Med 87:211-214, 1994
22. MACGUIRE GA, PRICE CP: A continuous monitoring spectrophotometric method for the measurement of angiotensin converting enzyme in human serum. Annal Clin Biochem 22:204-210, 1985
23. SCHUNKERT H, HENSE HW, HOLMER SR, STENDER M, PERZ S, KEIL U, LORELL BH, RIEGGER GA: Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 330:1634-1638, 1994
24. IWAI N, OHMICHI N, NAKAMURA Y, KINOSHITA M: DD genotype of the angiotensin-converting-enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 90:2622-2628, 1994
25. GHARAVI AG, PHILLIPS RA, DIAMOND JA, JHANG JS, LIPKOWITZ MS: Deletion polymorphism of the angiotensin converting enzyme gene is associated with concentric remodelling of the left ventricle. J Am Coll Cardiol 25:136A-137A, 1995
26. RAYNOLDS MV, BRISTOW MR, BUSH EW, ABRAHAM WT, LOWES BD, ZISMAN LS, TAFT CS, PERRYMAN MB: Angiotensin-converting enzyme DD genotype in patients with ischaemic or dilated cardiomyopathy. Lancet 342:1073-1075, 1993
27. MARIAN AJ, YU QT, WORKMAN R, GREVE G, ROBERTS R: Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 342:1085-1086, 1993
28. DORIA A, WARRAM JH, KROLEWSKI AS: Genetic predisposition to diabetic nephropathy. Diabetes 43:690-695, 1994
29. LINDPAINTNER K, PFEFFER MA, KREUTZ R, STAMPFER MJ, GRODSTEIN F, LAMOTTE F, BURING J, HENNEKENS CH: A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 332:706-711, 1995
30. LEVY D, LINDPAINTNER K, LARSON MG, RAMACHANDRAN VS, MYERS RH, PFEFFER MA, ORDOVAS JM, SCHAEFER EJ, WILSON WF: Left ventricular hypertrophy and the deletion-insertion polymorphism of the angiotensin converting enzyme gene. (abstract) J Am Coll Cardiol 25:136A, 1995
31. LINDPAINTNER K, HENNEKENS CH: Angiotensin-converting-enzyme genotype and ischemic heart disease. N Engl J Med 333:459-460, 1995
32. BARLEY J, BLACKWOOD A, CARTER ND, CREWS DE, CRUICKSHANK JK, JEFFERY S, OGUNLESI AO, SAGNELLA GA: Angiotensin converting enzyme insertion/deletion polymorphism: Association with ethnic origin. J Hypertens 12:955-957, 1994
33. SAGNELLA GA, BARLEY J, BLACKWOD A, MILLER M, MARKANDU ND, CARTER ND, JEFFERY S, CAPPUCCIO FP, MACGREGOR GA: Angiotensin 1 converting enzyme I/D polymorphism: Blood pressure and the renin-angiotensin system in Caucasians and Afro-Carribeans. (abstract) J Hum Hypertens 9:701, 1995
34. CAMBIEN F, ALHENC-GELAS F, HERBETH B, ANDRE JL, RAKOTOVAO R, GONZALES MF, ALLEGRINI J, BLOCK C: Familial resemblance of plasma angiotensin converting enzyme level: The Nancy study. Am J Hum Genet 43:774-780, 1988
35. JEUNEMAITRE K, LIFTON RP, HUNT SC, WILLIAMS RR, LAOUEL JM: Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nature Genet 1:72-75, 1992
36. RUDNICK KV, SACKETT DL, HIRST S, HOLMES D: Hypertension in a family practice. Can Med Assoc J 117:492-497, 1977
37. GIFFORD RWJ: Evaluation of the hypertensive patient with emphasis on detecting curable causes. Milbank Med Found Quart 37:170-186, 1969